Home » Topics » BioWorld Science

BioWorld Science
RSS

New MAP4K1 inhibitors identified at Blueprint Medicines

Aug. 11, 2021

Jiangsu Chia Tai Tianqing Pharmaceutical Group patents BCR-ABL inhibitors

Aug. 11, 2021

New PSMB8 inhibitors divulged by Shouyao Holdings

Aug. 11, 2021

Final topline data presented from DeCidE1 study of MVP-S in ovarian cancer

Aug. 11, 2021

Resveratrol-triggered switches maximize cancer immunotherapy, reduce toxicity

Aug. 11, 2021

Second interim analysis data from phase IIa study of vilobelimab in pyoderma gangrenosum

Aug. 11, 2021

First patient dosed in phase I study of APL-102

Aug. 10, 2021

Ohio State University describes looped proteins comprising cell-penetrating peptides

Aug. 10, 2021

Stress hormones affect brain plasticity via distinct mechanisms

Aug. 10, 2021

AAV2-hAADC gene therapy shows safety and efficacy in children with AADC deficiency

Aug. 10, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...